AM-101 in the Treatment of Post-Acute Tinnitus 2
NCT02040207 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 487
Last updated 2023-09-14
Summary
The purpose of this research study is to test the safety and local tolerance of repeated treatment with AM-101.
Conditions
- Tinnitus
Interventions
- DRUG
-
AM-101
AM-101 gel for intratympanic injection
Sponsors & Collaborators
-
Auris Medical AG
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 76 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-06-30
- Primary Completion
- 2016-12-31
- Completion
- 2016-12-31
Countries
- Germany
Study Locations
More Related Trials
-
OTO-313 in Subjects With Unilateral Subjective Tinnitus
NCT04829214 ·Status: COMPLETED ·Phase: PHASE2
-
AM-111 in the Treatment of Acute Inner Ear Hearing Loss
NCT02561091 ·Status: COMPLETED ·Phase: PHASE3
-
OTO-313 in Subjects With Subjective Tinnitus
NCT03918109 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Open Label Study of OTO-104 in Subjects With Meniere's Disease
NCT02740387 ·Status: TERMINATED ·Phase: PHASE2
-
Evaluating Possible Improvement in Tinnitus Severity After 28 Days Dosing of the Study Drug AUT00063 Compared to Placebo
NCT02315508 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment Evaluation of Neuromodulation for Tinnitus - Stage A2
NCT03530306 ·Status: COMPLETED ·Phase: NA
-
Efficacy of AM-111 in Patients With Acute Sensorineural Hearing Loss
NCT00802425 ·Status: COMPLETED ·Phase: PHASE2
-
Safety Study for NST-001 and the Neuroject Injection Set to Treat Tinnitus
NCT00957788 ·Status: TERMINATED ·Phase: PHASE1
-
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
NCT02809118 ·Status: TERMINATED ·Phase: PHASE3
-
Study of OTO-104 in Subjects With Unilateral Meniere's Disease
NCT02612337 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Trial of Acamprosate for Tinnitus
NCT00596531 ·Status: COMPLETED ·Phase: PHASE1
-
OTO-104 for the Treatment of Meniere's Disease
NCT01412177 ·Status: COMPLETED ·Phase: PHASE2
-
FX-322 in Adults With Stable Sensorineural Hearing Loss
NCT04120116 ·Status: COMPLETED ·Phase: PHASE2
-
Investigation of Kinetic Oscillation Stimulation by the Chordate System S101 in the Treatment of Non Allergic Rhinitis
NCT03399721 ·Status: COMPLETED ·Phase: NA
-
Phase 3 Study of OTO-104 in Subjects With Unilateral Meniere's Disease
NCT03664674 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate SPI-1005 in Adults With Meniere's Disease
NCT02603081 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study of OTO-104 in Subjects With Unilateral Meniere's Disease
NCT02717442 ·Status: TERMINATED ·Phase: PHASE3
-
OTO-413 in Subjects With Speech-in-Noise Hearing Impairment
NCT04129775 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Magnetic Resonance Imaging Evaluation of Inner Ear Pathology Using Intra-Tympanic Contrast Agent
NCT02080312 ·Status: COMPLETED ·Phase: NA
-
Open-Label, Long-Term Treatment Study, to Assess the Long-Term Safety and Tolerability and Efficacy of Neramexane in Patients With Subjective Tinnitus
NCT00827008 ·Status: TERMINATED ·Phase: PHASE3
-
A 6-Month Extension Study of OTO-104 in Meniere's Disease
NCT02706730 ·Status: TERMINATED ·Phase: PHASE3
-
Study of BGG492 in Patients With Chronic Subjective Tinnitus
NCT01302873 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of SENS 401 in Healthy Subjects
NCT03071003 ·Status: COMPLETED ·Phase: PHASE1
-
A 1-Year Safety Study of OTO-104 in Subjects With Unilateral Meniere's Disease Located in United Kingdom
NCT02265393 ·Status: COMPLETED ·Phase: PHASE2
-
FX-322 in Adults With Severe Sensorineural Hearing Loss
NCT04629664 ·Status: COMPLETED ·Phase: PHASE1